Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.

Taupin P

Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.

2006

Taupin P

: San Raffaele Telethon Institute for Gene Therapy is developing an adenosine deaminase-transduced hematopoietic stem cell therapy for the potential intravenous treatment of adenosine deaminase deficiency in severe combined immunocompromised individuals.

Keywords:

Hematopoietic stem cell
Cancer research
Biology
Drug
Adenosine
Genetic enhancement
Adenosine deaminase deficiency
intravenous treatment
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations